233 related articles for article (PubMed ID: 21270266)
1. Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice.
Racine J; Wang M; Zhang C; Lin CL; Liu H; Todorov I; Atkinson M; Zeng D
Diabetes; 2011 Feb; 60(2):555-64. PubMed ID: 21270266
[TBL] [Abstract][Full Text] [Related]
2. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
3. MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.
Zhang M; Racine JJ; Lin Q; Liu Y; Tang S; Qin Q; Qi T; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2329-E2337. PubMed ID: 29463744
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
Su M; Lin Y; He Z; Lai L
Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
[TBL] [Abstract][Full Text] [Related]
5. Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD mice.
Racine JJ; Wang M; Zhang M; Zeng D
Diabetes; 2014 Jun; 63(6):2051-62. PubMed ID: 24458357
[TBL] [Abstract][Full Text] [Related]
6. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
[TBL] [Abstract][Full Text] [Related]
7. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
[TBL] [Abstract][Full Text] [Related]
8. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
[TBL] [Abstract][Full Text] [Related]
9. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
10. Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism.
Huang Y; Wu X; Tang S; Wu H; Nasri U; Qin Q; Song Q; Wang B; Tao H; Chong AS; Riggs AD; Zeng D
Am J Transplant; 2023 Aug; 23(8):1116-1129. PubMed ID: 37105316
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
[TBL] [Abstract][Full Text] [Related]
12. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
[TBL] [Abstract][Full Text] [Related]
13. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
Nikolic B; Onoe T; Takeuchi Y; Khalpey Z; Primo V; Leykin I; Smith RN; Sykes M
Transplantation; 2010 Jan; 89(1):23-32. PubMed ID: 20061915
[TBL] [Abstract][Full Text] [Related]
14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
15. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
16. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
Truitt RL; Atasoylu AA
Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
[TBL] [Abstract][Full Text] [Related]
17. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
Good RA
World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
[TBL] [Abstract][Full Text] [Related]
18. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.
Liang Y; Huang T; Zhang C; Todorov I; Atkinson M; Kandeel F; Forman S; Zeng D
Blood; 2005 Mar; 105(5):2180-8. PubMed ID: 15374883
[TBL] [Abstract][Full Text] [Related]
19. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
